Literature DB >> 12509636

Adverse effects of intravenous lignocaine therapy in fibromyalgia syndrome.

J H Raphael, J L Southall, G D Kitas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12509636     DOI： 10.1093/rheumatology/keg027

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  3 in total

Review 1.  [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline].

Authors:  C Sommer; W Häuser; R Alten; F Petzke; M Späth; T Tölle; N Uçeyler; A Winkelmann; E Winter; K J Bär
Journal:  Schmerz       Date:  2012-06       Impact factor: 1.107

2.  Osteoarthritis pain has a significant neuropathic component: an exploratory in vivo patient model.

Authors:  Rui V Duarte; Jon H Raphael; Theodoros Dimitroulas; Elizabeth Sparkes; Jane L Southall; Robert L Ashford; George D Kitas
Journal:  Rheumatol Int       Date:  2013-11-10       Impact factor: 2.631

3.  Durability of Benefit From Repeated Intravenous Lidocaine Infusions in Fibromyalgia Patients: A Case Series and Literature Review.

Authors:  David M Marks; Amy Newhouse
Journal:  Prim Care Companion CNS Disord       Date:  2015-09-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.